Development, launch, and scale-up of health products in low-income and middle-income countries: a retrospective analysis on 59 health products.
Date
2025-06
Journal Title
Journal ISSN
Volume Title
Repository Usage Stats
views
downloads
Citation Stats
Attention Stats
Abstract
Background
Low-income and middle-income countries (LMICs) bear a heavy burden from communicable, maternal, and childhood diseases, yet access to health products addressing these burdens is lagging. We aimed to provide empirical evidence about the timelines, and influencing factors, of the end-to-end scale-up pathway of health products in LMICs.Methods
We identified products that met our prespecified inclusion criteria. We documented the dates and intervals for five key milestones in the pathway: ideation, proof of concept, regulatory approval, first LMIC country launch, and at least 20% uptake across LMICs. We then explored the association between pace of this pathway and ten characteristics, such as product types, buying environment, and market type. We used robust regression models to test our hypothesis that multiple factors affect a product's pathway to scale-up in LMICs.Findings
Among 59 included products, the median time to bring a product from ideation to at least 20% uptake in LMICs was 13·5 years (IQR 6·8-41·6). Ideation to proof of concept was the longest interval (median 6·9 years) for most product types, followed by the first country launch to at least 20% uptake in LMICs (median 3·8 years). Infectious disease products tended to need the longest time to launch, whereas maternal and child health products took the longest to scale up. Products with consumer or institutional markets launched and scaled up faster than those with global markets by 6 years and 2 years, respectively (p=0·012 and p<0·0001). Other factors, such as type of developer and buying environment, also had an effect on launch and scale-up timelines.Interpretation
Stakeholders should make long-term plans to introduce and scale up new products. Better coordination and planning across different stages and among different players could accelerate the process.Funding
Bill & Melinda Gates Foundation.Type
Department
Description
Provenance
Subjects
Citation
Permalink
Published Version (Please cite this version)
Publication Info
Mao, Wenhui, Elina Urli Hodges, Armand Zimmerman, Ernesto J Ortiz, Kelly Kilburn, Diana Silimperi and Krishna Udayakumar (2025). Development, launch, and scale-up of health products in low-income and middle-income countries: a retrospective analysis on 59 health products. The Lancet. Global health, 13(6). pp. e1132–e1139. 10.1016/s2214-109x(25)00062-2 Retrieved from https://hdl.handle.net/10161/33817.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
Collections
Scholars@Duke
Wenhui Mao
Ernesto Ortiz
Krishnakumar Udayakumar
Dr. Krishna Udayakumar is the founding Director of the Duke Global Health Innovation Center, focused on generating deeper evidence and support for the study, scaling, and adaptation of health innovations and policy reforms globally. He is also Executive Director of Innovations in Healthcare, a non-profit co-founded by Duke, McKinsey & Company, and the World Economic Forum to curate and scale the impact of transformative health solutions globally.
At Duke University, Dr. Udayakumar holds the rank of Professor of Global Health along with a secondary faculty appointment in Medicine. He is a core faculty member of the Duke-Margolis Institute for Health Policy. His work has been published in leading academic journals such as the New England Journal of Medicine, Health Affairs, and Academic Medicine.
Born in Bangalore, India, Dr. Udayakumar spent his childhood in Virginia, and is a Phi Beta Kappa graduate of the University of Virginia, with a bachelor’s degree in interdisciplinary studies with distinction. He received both an MD and an MBA (with a concentration in Health Sector Management) from Duke University, where he was a Fuqua Scholar. Dr. Udayakumar completed his residency training in internal medicine at Duke and served as Assistant Chief Resident at the Durham VA Medical Center before joining the faculty of Duke University.
Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.
